HAEMONETICS CORP — Director's Dealing 2017

Aug 15, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2017-08-10

Reporting Person: MEELIA RICHARD J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-10	Common Stock	M	16968	$32.96	Acquired	43879	Direct
2017-08-10	Common Stock	S	16968	$42.02	Disposed	26911	Direct
2017-08-10	Common Stock	M	7118	$34.405	Acquired	34029	Direct
2017-08-10	Common Stock	S	7118	$42.1046	Disposed	26911	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-10	Non-qualified Stock Option (Right to Buy)	$32.96	M	16968	Disposed	2018-06-03	Common Stock (16968)	Direct
2017-08-10	Non-qualified Stock Option (Right to Buy)	$34.405	M	7118	Disposed	2018-07-21	Common Stock (7118)	Direct

Footnotes

F1: Represents the exercise and sale of stock options which expire in June 2018.

F2: Represents the exercise and sale of stock options which expire in July 2018.